Skip to main content

Table 7 Associations between pre-DM and T2DM with TG/HDL-C according to smoking status

From: Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China

Variables

Model 1 a

Model 2 b

Pre-DM

T2DM

Pre-DM

T2DM

OR (95% CI)

OR (95% CI)

OR (95% CI)

OR (95% CI)

TG/HDL-C

 Yes

  Total

1.15 (1.11–1.18) **

1.29 (1.25–1.33) **

1.16 (1.11–1.20) **

1.30 (1.26–1.34) **

  T1

Reference

Reference

Reference

Reference

  T2

1.18 (1.05–1.33) *

1.37 (1.24–1.52) **

1.20 (1.06–1.34) *

1.43 (1.28–1.59) **

  T3

1.43 (1.27–1.62) **

2.50 (2.26–2.78) **

1.47 (1.30–1.66) **

2.63 (2.35–2.92) **

  P trend

 < 0.001

 < 0.001

 < 0.001

 < 0.001

  Low

Reference

Reference

Reference

Reference

  High

1.59 (1.34–1.88) **

2.82 (2.44–3.26) **

1.62 (1.36–1.92) **

2.84 (2.45–3.29) **

 No

  Total

1.25 (1.21–1.30) **

1.44 (1.39–1.50) **

1.27 (1.21–1.32) **

1.46 (1.40–1.51) **

  T1

Reference

Reference

Reference

Reference

  T2

1.23 (1.12–1.35) **

1.55 (1.42–1.60) **

1.24 (1.12–1.36) **

1.55 (1.42–1.70) **

  T3

1.66 (1.50–1.85) **

2.84 (2.59–3.12) **

1.72 (1.54–1.91) **

2.91 (2.65–3.20) **

  P trend

 < 0.001

 < 0.001

 < 0.001

 < 0.001

  Low

Reference

Reference

Reference

Reference

  High

1.71 (1.50–1.95) **

2.69 (2.39–3.02) **

1.74 (1.52–2.00) **

2.83 (2.51–3.18) **

  1. aModel 1: unadjusted;
  2. bModel 2: adjusted for age, sex, SBP, hypertension, family history of DM, current antilipidemic medication, current antihypertensive medication
  3. Compared with NG, *P < 0.05, **P < 0.01